This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
R Armitage , RF Hoffman (2001). Sleep EEG, depression and gender. Sleep Medicine Reviews 5, 237–246.
AA Borbely , I Tobler , M Loepfe , DJ Kupfer , RF Ulrich , V Grochocinski , J Doman , G Matthews (1984). All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Research 12, 27–33.
CL Ehlers , JW Havstad , DJ Kupfer (1996). Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response. Biological Psychiatry 39, 171–181.
I Feinberg , TC Floyd (1979). Systematic trends across the night in human sleep cycles. Psychophysiology 16, 283–291.
E Fuchs , B Schmelting , E Mocaër (2006). Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depression. European Neuropsychopharmacology 16 (Suppl. 4), S338.
JA Hicks , SV Argyropoulos , AS Rich , JR Nash , CJ Bell , C Edwards , DJ Nutt , SJ Wilson (2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. British Journal of Psychiatry 180, 528–535.
RD Jindal , ES Friedman , SR Berman , AL Fasiczka , RH Howland , ME Thase (2003). Effects of sertraline on sleep architecture in patients with depression. Journal of Clinical Psychopharmacology 23, 540–548.
S Kantor , R Jakus , R Bodizs , P Halasz , G Bagdy (2002). Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift. Brain Research 943, 105–111.
SH Kennedy , R Emsley (2006). Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. European Neuropsychopharmacology 16, 93–100.
DJ Kupfer , E Frank , AB McEachran , VJ Grochocinski (1990). Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Archives of General Psychiatry 47, 1100–1105.
DJ Kupfer , CL Ehlers , E Frank , VJ Grochocinski , AB McEachran , A Buhari (1994). Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biological Psychiatry 35, 781–793.
R Leproult , A Van Onderbergen , M L'hermite-Baleriaux , E Van Cauter , G Copinschi (2005). Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clinical Endocrinology 63, 298–304.
MJ Millan , A Gobert , F Lejeune , A Dekeyne , A Newman-Tancredi , V Pasteau , JM Rivet , D Cussac (2003). The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. Journal of Pharmacology and Experimental Therapeutics 306, 954–964.
J Mouret , P Lemoine , MP Minuit , C Benkelfat , M Renardet (1988). Effects of trazodone on the sleep of depressed subjects – a polygraphic study. Psychopharmacology (Berlin) 95 (Suppl.), S37–43.
J Taillard , P Sanchez , P Lemoine , J Mouret (1990). Heart rate circadian rhythm as a biological marker of desynchronization in major depression. Chronobiology International 7, 305–316.
S Willson , SV Argyropoulos (2005). Antidepressants and sleep: a qualitative review of the literature. Drugs 65, 927–947.